0001678660-17-000001.txt : 20171020
0001678660-17-000001.hdr.sgml : 20171020
20171020160658
ACCESSION NUMBER: 0001678660-17-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20171020
DATE AS OF CHANGE: 20171020
EFFECTIVENESS DATE: 20171020
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Prelude Therapeutics Inc.
CENTRAL INDEX KEY: 0001678660
IRS NUMBER: 811384762
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-297174
FILM NUMBER: 171147103
BUSINESS ADDRESS:
STREET 1: 550 S COLLEGE AVE.
CITY: NEWARK
STATE: DE
ZIP: 19713
BUSINESS PHONE: (302) 547-3768
MAIL ADDRESS:
STREET 1: 550 S COLLEGE AVE.
CITY: NEWARK
STATE: DE
ZIP: 19713
D
1
primary_doc.xml
X0708
D
LIVE
0001678660
Prelude Therapeutics Inc.
550 S COLLEGE AVE.
STE. 108
NEWARK
DE
DELAWARE
19713
(302) 547-3768
DELAWARE
None
None
Corporation
true
2016
Krishna
Vaddi
c/o Prelude Therapeutics Inc.
550 S College Ave., Ste. 108
Newark
DE
DELAWARE
19713
Executive Officer
Director
Director, Chief Executive Officer, President and Secretary of Issuer
Paul
Friedman
c/o Prelude Therapeutics Inc.
550 S College Ave., Ste. 108
Newark
DE
DELAWARE
19713
Director
Director of Issuer
David
Bonita
c/o Prelude Therapeutics Inc.
550 S College Ave., Ste. 108
Newark
DE
DELAWARE
19713
Director
Director of Issuer
Kelvin
Neu
c/o Prelude Therapeutics Inc.
550 S College Ave., Ste. 108
Newark
DE
DELAWARE
19713
Director
Director of Issuer
Juan
Luengo
c/o Prelude Therapeutics Inc.
550 S College Ave., Ste. 108
Newark
DE
DELAWARE
19713
Executive Officer
Vice President of Issuer
Biotechnology
Decline to Disclose
- 06b
false
2017-10-06
false
true
false
0
12000000
12000000
0
false
7
0
0
0
false
Prelude Therapeutics Inc.
/s/ Krishna Vaddi
Krishna Vaddi
Director, CEO, President and Secretary
2017-10-20